CDHR3 rs2305161: Understanding Your Genetic Asthma Risk Factors
The rs2305161 variant is a genetic marker located within the CDHR3 gene, which provides instructions for a protein that acts as a receptor for rhinovirus C. Research indicates that certain variations in this gene are statistically associated with an increased risk of early-childhood wheezing illnesses and severe asthma exacerbations.
What each genotype means
Increased asthma risk
This genotype is associated with an increased risk for early-childhood wheezing and severe asthma exacerbations. Research indicates that this variant results in a specific protein structure (Tyr529) that may increase the susceptibility of airway cells to infection by rhinovirus C. Please discuss any concerns regarding respiratory health or asthma management with your clinician.
This genotype is the less common variant, carried by a minority of individuals in most populations.
Moderate asthma risk
This genotype represents a heterozygous state associated with a moderate risk for early-childhood wheezing and severe asthma exacerbations. The presence of one copy of the risk-associated allele may influence how airway cells interact with rhinovirus C. Please discuss any concerns regarding respiratory health or asthma management with your clinician.
This genotype is found at intermediate frequencies in many populations, reflecting the inheritance of one risk-associated allele.
Typical risk profile
This genotype is considered the more common or protective variant in the context of this specific genetic association. It results in a different protein structure (Cys529) compared to the risk-associated allele, which is linked to lower susceptibility to rhinovirus C infection in laboratory studies. This does not eliminate the risk of asthma, as asthma is a complex condition influenced by many genetic and environmental factors.
This is the most common genotype, carried by the majority of individuals worldwide.
What is the rs2305161 Variant?
The rs2305161 variant is a single-nucleotide polymorphism (SNP) situated within the CDHR3 (cadherin-related family member 3) gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is located in a region of the genome that has been identified through genome-wide association studies (GWAS) as a susceptibility locus for respiratory health traits. While the variant itself is a simple change in the DNA code, its presence is used by researchers to study how inherited genetic differences might influence an individual's biological response to environmental triggers, such as viral infections in the airway. It is important to note that identifying this variant does not mean an individual will develop a specific condition; rather, it represents a statistical correlation observed in large-scale population studies.
The Role of the CDHR3 Gene
The CDHR3 gene encodes a transmembrane protein that is primarily expressed in the epithelium of the human airways. This protein serves a critical biological function as the specific cell-surface receptor for rhinovirus C (RV-C), a common respiratory virus. When RV-C enters the respiratory tract, it binds to the CDHR3 protein to gain entry into host cells, where it can then replicate. Scientific research has demonstrated that variations in the CDHR3 gene can influence the expression levels or the structure of this receptor on the surface of airway cells. By altering how effectively the virus can bind to or enter these cells, genetic variations in CDHR3 may modulate an individual's susceptibility to RV-C infections. These infections are frequently linked to the onset of wheezing and the exacerbation of asthma symptoms in young children.
Research and Evidence Strength
The association between CDHR3 variants and childhood asthma is supported by multiple studies, though the evidence strength for any single SNP like rs2305161 is often categorized as limited or moderate in clinical contexts. Research has consistently shown that children with specific genetic profiles in this region are more likely to experience severe asthma exacerbations or recurrent wheezing during early childhood. However, asthma is a complex, polygenic condition, meaning it is influenced by many different genes and environmental factors working in concert. While the link between CDHR3 and RV-C susceptibility is well-documented in molecular biology, the clinical impact of a single SNP remains a subject of ongoing investigation. Current findings suggest that the effect of these variants is often dependent on interactions with other genes, such as GSDMB, and environmental exposures, highlighting the complexity of predicting health outcomes based on genetics alone.
What You Can Do With This Information
Genetic information regarding variants like rs2305161 is primarily intended for educational and research purposes. It is crucial to understand that this information cannot be used to diagnose asthma or predict the future development of respiratory conditions. Because asthma is influenced by a wide array of genetic and environmental factors, a single SNP result provides only a very small piece of a much larger puzzle. If you are concerned about your child's respiratory health, wheezing, or asthma symptoms, the most important step is to consult with a pediatrician or a respiratory specialist. They can provide a clinical evaluation based on symptoms, medical history, and physical examinations. Never use genetic data to make decisions about medications or treatments; always discuss any concerns regarding dosing or management plans with your healthcare provider or a licensed pharmacist.
How common is this variant?
The minor allele frequency for CDHR3 variants typically varies by ancestry, with frequencies around 0.15 in European populations and approximately 0.05 in East Asian populations.
Frequently asked questions
Does having a CDHR3 variant mean I have asthma?
No, having a specific CDHR3 variant does not mean you have or will develop asthma. Asthma is a complex condition influenced by many genetic and environmental factors, and genetic markers only indicate a statistical association, not a diagnosis.
Can I use this SNP to predict my child's asthma risk?
Genetic testing for single SNPs is not a reliable tool for predicting individual health outcomes. Clinical risk assessment for asthma is based on a child's medical history, symptoms, and professional evaluation by a doctor.
What is the link between CDHR3 and rhinovirus?
The CDHR3 protein acts as a receptor that allows rhinovirus C to enter and infect airway cells. Variations in the CDHR3 gene may affect how this receptor functions, potentially influencing susceptibility to these viral infections.
Should I change my asthma medication based on my genotype?
No, you should never change your medication or treatment plan based on genetic test results. Always consult with your physician or pharmacist before making any changes to prescribed asthma therapies.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2305161?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29